AbbVie (ABBV) Financials
AbbVie (ABBV) Historical Financial Statements and Key Metrics for 2011 - 2026
Full AbbVie financials for 2011 - 2026 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
AbbVie Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2026-Jun-30 | 16,990 | 12,699 (74.7 %) | 6,432 (37.9 %) | 3,613 (21.3 %) | 8,659 | 2.04 |
| 2026-Mar-31 | 15,002 | 10,784 (71.9 %) | 4,734 (31.6 %) | 699 (4.7 %) | 3,692 | 0.39 |
| 2025-Dec-31 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2025-Sep-30 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2025-Jun-30 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2025-Mar-31 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2024-Dec-31 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
Full historical income statements for 2011 - 2026 is included in the
US Historical Financials dataset.
AbbVie Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2026-Jun-30 | 135,134 | 141,003 | 70,822 | -5,935 | 6,569 |
| 2026-Mar-31 | 136,463 | 108,964 | 72,858 | 27,499 | 9,391 |
| 2025-Dec-31 | 133,960 | 137,188 | 68,874 | -3,270 | 5,257 |
| 2025-Sep-30 | 133,898 | 136,497 | 68,743 | -2,642 | 5,671 |
| 2025-Jun-30 | 137,182 | 137,320 | 70,481 | -183 | 6,467 |
| 2025-Mar-31 | 136,165 | 134,703 | 69,889 | 1,420 | 5,176 |
| 2024-Dec-31 | 135,161 | 131,797 | 67,144 | 3,325 | 5,555 |
Full historical balance sheet data for 2011 - 2026 is included in the
US Historical Financials dataset.
AbbVie Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2026-Jun-30 | 3,436 | -1,197 | -5,054 | 3,701 |
| 2026-Mar-31 | 3,829 | -574 | 919 | 3,564 |
| 2025-Dec-31 | 5,218 | -1,463 | -4,166 | 4,889 |
| 2025-Sep-30 | 0 | 0 | 0 | 0 |
| 2025-Jun-30 | 5,153 | -1,181 | -2,710 | 4,884 |
| 2025-Mar-31 | 1,635 | -735 | -1,258 | 1,400 |
| 2024-Dec-31 | 7,048 | -1,874 | -6,861 | 6,757 |
Full historical cash flow data for 2011 - 2026 is included in the
US Historical Financials dataset.
AbbVie Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2026-Jun-30 | 445,652 | 509,905 | 26.23 | 30.84 | -75.09 |
| 2026-Mar-31 | 385,798 | 449,265 | 25.72 | 139.42 | 14.03 |
| 2025-Dec-31 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2025-Sep-30 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2025-Jun-30 | 328,919 | 392,933 | 21.33 | 87.11 | -1,797.37 |
| 2025-Mar-31 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2024-Dec-31 | 0 | 0 | 0.00 | 0.00 | 0.00 |
Full historical valuation and operating metrics for 2011 - 2026 are included in the
US Historical Financials dataset.